Michael Hennig

Company: leadXpro

Job title: Chief Executive Officer

Seminars:

Structure Based Drug Discovery on Membrane Proteins at leadXpro 9:30 am

Discovery of novel small molecule binding sites to activate Kv3.1, TRPV4 Time resolved X-ray crystallography on GPCR’s to investigate structural dynamics of ligand binding Nanobodies and Pro-Macrobodies to facilitate structure determinationRead more

day: Day One